Compare VCEL & XZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | XZO |
|---|---|---|
| Founded | 1989 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 1996 | N/A |
| Metric | VCEL | XZO |
|---|---|---|
| Price | $36.30 | $13.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $57.75 | $27.00 |
| AVG Volume (30 Days) | ★ 588.4K | 263.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.40 | $9.11 |
| Revenue Next Year | $18.24 | $16.05 |
| P/E Ratio | ★ N/A | $18.63 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $12.36 |
| 52 Week High | $45.97 | $24.60 |
| Indicator | VCEL | XZO |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 41.76 |
| Support Level | $35.85 | $12.96 |
| Resistance Level | $38.31 | $16.65 |
| Average True Range (ATR) | 1.57 | 0.75 |
| MACD | 0.16 | 0.01 |
| Stochastic Oscillator | 81.12 | 30.70 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Exzeo Group Inc provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform, which it refers to as the Exzeo Platform, currently includes nine configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. Through the Exzeo Platform, the company provides technology-based solutions and services for all operational and administrative activities and functions needed by P&C insurance carriers and their agents.